O. Hauch

发表

[Venous thromboembolic disease and oral contraceptives].

K. Overgaard, O. Lidegaard, O. Hauch, 1986, Ugeskrift for laeger.

Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients.

J. Ofman, K. Knight, D. Aguilar, 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Monitoring anticoagulation in atrial fibrillation

M. Bullano, V. Willey, C. Sarawate, 2006, Journal of Thrombosis and Thrombolysis.

Incidence of death and recurring acute coronary syndrome after stopping clopidogrel therapy in a large commercially-insured population in the US

J. Stephenson, M. Cziraky, Chun‐Lan Chang, 2011, Current medical research and opinion.

Excess Ticagrelor Mortality: Reporting Bias or a Canary in the Coal Mine?

O. Hauch, 2017, The American journal of medicine.

Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

L. Bastholt, M. Kreissl, M. Schlumberger, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database.

J. Menzin, M. Friedman, G. Wygant, 2008, Current medical research and opinion.

Letter--Prudent Formulary Management or Underutilization of the Novel P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention?

O. Hauch, 2017, Journal of managed care & specialty pharmacy.

The Oral Contraceptive User

K. Overgaard, Ø. Lidegaard, O. Hauch, 1988, Acta obstetricia et gynecologica Scandinavica.

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis.

K. Fahrbach, M. Reynolds, L. Nalysnyk, 2004, Chest.

[A prospective controlled study of vagotomy in the treatment of duodenal ulcer. Results after 11-15 years].

H. Jensen, O. Hauch, A. Olesen, 1989, Ugeskrift for laeger.

Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey.

M. Ezekowitz, C. Gross, R. Edwards, 2003, Clinical therapeutics.

A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation

G. Samsa, D. Matchar, R. Edwards, 2004, Health and quality of life outcomes.

Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed

J. Stephenson, John Martin, S. Boccuzzi, 2009, Current medical research and opinion.

One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database*

J. Menzin, M. Friedman, G. Wygant, 2008 .

Warfarin Exposure and the Risk of Thromboembolic and Major Bleeding Events Among Medicaid Patients with Atrial Fibrillation

J. Menzin, M. Friedman, L. Boulanger, 2006, The Annals of pharmacotherapy.

Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system*

A. Vanderplas, K. H. Lew, T. Darkow, 2005, Current medical research and opinion.

Quality of Anticoagulation Control and Costs of Monitoring Warfarin Therapy among Patients with Atrial Fibrillation in Clinic Settings: A Multi-Site Managed-Care Study

J. Menzin, M. Friedman, L. Boulanger, 2005, The Annals of pharmacotherapy.

Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.

M. Bullano, V. Willey, M. Reynolds, 2004, Clinical therapeutics.

Quality of Anticoagulation Monitoring in Nonvalvular Atrial Fibrillation Patients: Comparison of Anticoagulation Clinic versus Usual Care

Tara K. Knight, Tara K Knight, Ole Hauch, 2008, The Annals of pharmacotherapy.

Evaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrel

A. Riedel, G. Wygant, O. Hauch, 2009, Current medical research and opinion.

Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non‐valvular atrial fibrillation in clinical practice

M. Friedman, L. Boulanger, T. Foster, 2006, International journal of clinical practice.

Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.

J. Caro, S. Gottlieb, P. Deedwania, 2005, Journal of cardiac failure.

Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization

M. Bullano, V. Willey, A. Spyropoulos, 2005, Journal of managed care pharmacy : JMCP.

Frequency of Concurrent Use of Warfarin with Potentially Interacting Drugs

A. Wittkowsky, J. Wogen, S. Boccuzzi, 2004, Pharmacotherapy.

Prospective Controlled Vagotomy Trial for Duodenal Ulcer. Results After 11–15 Years

J. Christiansen, H. Jensen, O. Hauch, 1989, Annals of surgery.

Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis*

C. Harley, A. Riedel, M. Nelson, 2005, Current medical research and opinion.

Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study.

L. Wallentin, M. Janzon, M. Henriksson, 2013, European heart journal.

Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.

M. Heuser, Olga M Klibanov, O. Hauch, 2023, Future oncology.

A Validation Study of the Rank-Preserving Structural Failure Time Model: Confidence Intervals and Unique, Multiple, and Erroneous Solutions

Mario Ouwens, Ole Hauch, Stefan Franzén, 2018, Medical decision making : an international journal of the Society for Medical Decision Making.

Screening for Campylobacter pyloridis in patients with upper dyspepsia and the relation to inflammation of the human gastric antrum.

B. Hansen, H. Raskov, K. Gaarslev, 1987, Scandinavian journal of gastroenterology.

Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed

J. Stephenson, John Martin, S. Boccuzzi, 2009, Current medical research and opinion.